Neuro-urologyLow-dose Desmopressin (cas 16679-58-6) Orally Disintegrating Tablet: Suggested Clinically Meaningful Benefit in Patients with Nocturia Due to Nocturnal Polyuria
-
Add time:09/27/2019 Source:sciencedirect.com
BackgroundClinical benefit has not been evaluated much in patients with nocturia.
We also recommend Trading Suppliers and Manufacturers of Desmopressin (cas 16679-58-6). Pls Click Website Link as below: cas 16679-58-6 suppliers
Prev:Clinical studyCohort analysis of Desmopressin (cas 16679-58-6) effect on hematoma expansion in patients with spontaneous intracerebral hemorrhage and documented pre-ictus antiplatelet use
Next:Clinical Research StudyOutcomes in Severe Hyponatremia Treated With and Without Desmopressin (cas 16679-58-6)) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Clinical Research StudyOutcomes in Severe Hyponatremia Treated With and Without Desmopressin (cas 16679-58-6)10/01/2019
- Clinical studyCohort analysis of Desmopressin (cas 16679-58-6) effect on hematoma expansion in patients with spontaneous intracerebral hemorrhage and documented pre-ictus antiplatelet use09/26/2019
- ‘Frequently recurring’ nocturnal polyuria is predictive of response to Desmopressin (cas 16679-58-6) in monosymptomatic nocturnal enuresis in childhood09/25/2019
- ReviewOral Desmopressin (cas 16679-58-6) in nocturia with benign prostatic hyperplasia: A systematic review of the literature09/24/2019
- Original ContributionDesmopressin (cas 16679-58-6)/indomethacin combination efficacy and safety in renal colic pain management: A randomized placebo controlled trial09/10/2019
- 62 - Desmopressin (cas 16679-58-6) (DDAVP)09/09/2019
- Meloxicam-Desmopressin (cas 16679-58-6) drug-drug interaction producing hyponatremia09/08/2019
- Constipation in nocturnal enuresis may interfere Desmopressin (cas 16679-58-6) management success09/07/2019
- ReviewUse of Desmopressin (cas 16679-58-6) in Hyponatremia: Foe and Friend09/06/2019
-
Health and Chemical more >
-
Related Products